Allsop et al evaluate the safety and efficacy of nabiximols treating cannabis withdrawal with use of a 6-day regimen of nabiximols or placebo with standardized psychosocial interventions during a 9-day admission.
This randomized clinical trial investigates the preliminary finding that the sweet-liking phenotype interacts with a high level of craving for alcohol to improve the response to naltrexone in patients with alcohol dependence.
This nonrandomized trial compares the effects of an intervention comprising manual-guided sessions on health care engagement and health information technology use vs usual care on self-reported substance use and depression.
Sigmon et al evaluate the relative efficacy of 1-, 2-, and 4-week buprenorphine tapering regimens and subsequent naltrexone therapy in outpatients with prescription opioid dependence.
Bowen et al compared the long-term efficacy of mindfulness-based relapse prevention with the efficacy of cognitive-behavioral relapse prevention and treatment as usual in participants who had successfully completed initial treatment for substance use disorders.
Wen et al examine the effect of state-level substance use disorder (SUD) parity laws on state-aggregate SUD treatment rates and the effect of recent federal SUD parity legislation.